OctoPlus wins drug development and manufacturing contract from Danish pharmaceutical company

07-Jul-2011 - Netherlands

OctoPlus N.V.  announced that a process development and manufacturing contract has been signed with a pharmaceutical company headquartered in Denmark. The undisclosed contract value will make a material contribution to OctoPlus' annual revenues.

Under the contract terms, OctoPlus will perform process development and manufacturing of a microsphere-based formulation for our client.

Other news from the department business & finance

Most read news

More news from our other portals

So close that even
molecules turn red...